Tail-Interacting Protein 47 (NT) Blocking Peptide

Home/Control Peptides/Tail-Interacting Protein 47 (NT) Blocking Peptide

Pricing & Details

Product No.T298
Protein
Tail-Interacting Protein 47
Formats AvailableView All
Product Type
Blocking Peptide
Alternate Names
TIP47, Mannose-6-Phosphate Receptor Binding Protein 1, Placental Protein 17
Applications
IHC FFPE
,
N
,
WB
Prod No.
Size
Price
Avail.
Qty
Add to cart
T298-50 µg
50 µg
$110.00
In stock
Max:
Min: 1
Step: 1
Contact Us For Academic mAb Advantage Pricing

Antibody Details

Product Details

Reactivity Species
Human
Product Concentration
0.2 mg/ml
Amino Acid Location
14 amino acids near the amino terminus of human TIP47.
Formulation
This peptide is formulated in PBS pH 7.2 (0.01 M Sodium Phosphate, 0.13 M NaCl) containing 0.1% bovine serum albumin and 0.02% sodium azide.
Storage and Handling
Store this peptide in working aliquots at -20°C in a manual defrost freezer. Avoid Repeated Freeze Thaw Cycles.
Country of Origin
USA
Shipping
Next Day Ambient
Each investigator should determine their own optimal working dilution for specific applications. See directions on lot specific datasheets, as information may periodically change.
Background
Tail-Interacting Protein 47 peptide is applicable as a control peptide for blocking antibody binding in Western blotting.

Antigen Details

References & Citations

1. Krokan HE, Otterlei M, Nilsen H, et al. Properties and functions of human uracil-DNA glycosylase from the UNG gene. Prog. Nucleic Acid Res. Mol. Biol. 2001; 68:365-86. 2. Fromm JC and Verdine GL. Base excision repair. Adv. Protein Chem. 2004; 69:1-41. 3. Kachhap S and Singh KK. Mitochondrial inhibition of uracil-DNA glycosylase is not mutagenic. Mol. Cancer 2004; 3:32. 4. Imam SZ, Karahalil B, Hogue BA, et al. Mitochondrial and nuclear DNA-repair capacity of various brain regions in mouse is altered in an age-dependent manner. Neurobiol. Aging 2006; 27:1129-36.
IHC
General Western Blot Protocol
Products are for research use only. Not for use in diagnostic or therapeutic procedures.
Leinco Technologies uses cookies to improve your experience and our website service. By continuing to browse our website, you accept our cookie policy. Ok